Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Poly(ADP-ribose) polymerase inhibition reverses vascular dysfunction after {gamma}-irradiation

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1];  [1];  [1];  [1];  [2];  [3];  [3];  [3];  [4];  [1];  [5];  [1]
  1. Department of Cardiac Surgery, University of Heidelberg, Heidelberg (Germany)
  2. Department of Clinical Radiology, University of Heidelberg, Heidelberg (Germany)
  3. Department of Pathology, University of Heidelberg, Heidelberg (Germany)
  4. Department of Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg (Germany)
  5. Department of Human Physiology and Clinical Experimental Research, Semmelweis University, Budapest (Hungary)
Purpose: The generation of reactive oxygen species during {gamma}-irradiation may induce DNA damage, leading to activation of the nuclear enzyme poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) culminating in endothelial dysfunction. In the present study, we assessed the effect of PARP inhibition on changes in vascular function after acute and short-term irradiation. Methods and Materials: In the acute experiments, aortic rings were exposed to 20 Gy of {gamma}-irradiation. The aortae were harvested after 1 or 7 days. Two additional groups received the ultrapotent PARP inhibitor, INO-1001, for 1 or 7 days after irradiation. The aortic rings were precontracted by phenylephrine and relaxation to acetylcholine and sodium nitroprusside were studied. Results: The vasoconstrictor response to phenylephrine was significantly lower both acutely and 1 and 7 days after irradiation. Vasorelaxation to acetylcholine and sodium nitroprusside was not impaired acutely after irradiation. One and seven days after irradiation, vasorelaxation to acetylcholine and sodium nitroprusside was significantly enhanced. Treatment with INO-1001 reversed vascular dysfunction after irradiation. Conclusion: Vascular dysfunction was observed 1 and 7 days after irradiation, as evidenced by reduced vasoconstriction, coupled with endothelium-dependent and -independent hyperrelaxation. PARP inhibition restored vascular function and may, therefore, be suitable to reverse vascular dysfunction after irradiation.
OSTI ID:
20850038
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 5 Vol. 65; ISSN IOBPD3; ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

Poly(ADP-ribose) polymerase-1 protects from oxidative stress induced endothelial dysfunction
Journal Article · Fri Nov 04 00:00:00 EDT 2011 · Biochemical and Biophysical Research Communications · OSTI ID:22207544

Atorvastatin restores arsenic-induced vascular dysfunction in rats: Modulation of nitric oxide signaling and inflammatory mediators
Journal Article · Wed Oct 01 00:00:00 EDT 2014 · Toxicology and Applied Pharmacology · OSTI ID:22439857

Poly(ADP-ribose) polymerase inhibition combined with irradiation: A dual treatment concept to prevent neointimal hyperplasia after endarterectomy
Journal Article · Tue Oct 31 23:00:00 EST 2006 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20850174